Murine norovirus.

Monvia Begins ASX Trading After $17.5M IPO

Monvia outlined its post-listing shareholder base, noting 295 registered holders with a custodian arrangement that can mask underlying investors, and highlighted governance groundwork including a Board Charter and a Remuneration and Nomination Committee ahead of ASX listing. It also disclosed a fully underwritten 17.5 million capital raise via a replacement prospectus, with capital allocated for strategic initiatives and the redemption of Series B Preference Shares, culminating in ASX admission on 22 July 2026 and trading from 24 July under the ticker MNV.